BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
MYC
,
cell-cell adhesion
,
Ischemia
,
Liver
,
Autoimmunity
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CNS
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Pediatric CNS tumors and normal pediatric CNS tissues
Mouse Phenotypes - Degenerative disease of the CNS
Genomics Assisted Toxicity Evaluation system study - Rat Kidney Repeat Dose
Ventral tegmental area of alcohol preferring rats after EtOH treatment regime
Extended amygdala tissues from alcohol-preferring (P) rats given access to ethanol or water
Explore Curated Studies Results
Literature
Most Relevant Literature
High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitami…
Oligodendrocyte death results in immune-mediated CNS demyelination.
MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chine…
Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
Recurrent visual loss in a 64-year-old man.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rare CNS Tumors Outcomes &Risk
CNS Infections Effect on the Inner Ear
Axi-cel in CNS Lymphoma
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
Venetoclax and Obinutuzumab for Relapsed Primary CNS Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ